Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy.

Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy.
复制标题

DOI:
10.1371/journal.pone.0264674
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
Davis, Carla M.
Davis, Carla M.
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Anvari, Sara;Watkin, Levi B.;Minard, Charles G.;Schuster, Kimberly;Hassan, Oluwatomi;Anagnostou, Aikaterini;Orange, Jordan S.;Corry, David B.;Davis, Carla M.

文献摘要

参考文献

被引文献

相似文献

Dendritic cells are important mediators in the early presentation of antigen and regulation of the differentiation of T cells. Peanut oral immunotherapy (POIT) results in desensitization in most peanut allergic individuals (responders), but not in others due to allergic reactions (non-responders). Delineation of early immunologic changes contributing to desensitization would help clarify the POIT mechanism of action. We analyzed dendritic cells in 15 pediatric subjects (5–12 years) undergoing a phase 1 single-center POIT study. We examined dendritic cells at baseline, 6-, 12-, 18- and 24-weeks after initiation of POIT and responders of therapy were compared to non-responders and healthy controls. The distribution frequency of myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) from peripheral blood samples were measured in vitro. A general linear mixed model was used, and included fixed effects for cohort (responder, non-responder, or healthy control), time (0-, 6-, 12-, 18-, and 24-weeks), and the cohort-time interaction term. P-values were adjusted for multiple hypothesis testing using Tukey’s method. We observed that POIT responders had reduced TNFa producing myeloid dendritic cells (mDCs) compared to non-responders. Additionally, non-responders had increased OX40L expressing mDCs at 18-weeks compared to responders. In conclusion, our findings suggest that a reduced pro-inflammatory phenotype in DCs could potentially serve as a predictor of early outcome and success of POIT desensitization.
DOI: 10.1111/imm.12888
发表时间: 2018-05
期刊: Immunology
影响因子: 6.4
作者:
Collin M;Bigley V
通讯作者: Bigley V
DOI: 10.1038/mi.2014.29
发表时间: 2014-11-01
期刊: MUCOSAL IMMUNOLOGY
影响因子: 8
作者:
Chu, D. K.;Mohammed-Ali, Z.;Jordana, M.
通讯作者: Jordana, M.
DOI: 10.3390/children5040047
发表时间: 2018-04-04
期刊: Children (Basel, Switzerland)
影响因子: --
作者:
Anvari S;Anagnostou K
通讯作者: Anagnostou K
DOI: 10.1016/j.jaci.2017.05.045
发表时间: 2018-01-01
影响因子: 14.2
作者:
Pellerin, Laurence;Jenks, Jennifer Anne;Bacchetta, Rosa
通讯作者: Bacchetta, Rosa
DOI: 10.3389/fimmu.2018.02572
发表时间: 2018
影响因子: 7.3
作者:
Ahmad S;Azid NA;Boer JC;Lim J;Chen X;Plebanski M;Mohamud R
通讯作者: Mohamud R